ZA200605930B - Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxyl}ethyl}-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-one - Google Patents
Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxyl}ethyl}-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-oneInfo
- Publication number
- ZA200605930B ZA200605930B ZA200605930A ZA200605930A ZA200605930B ZA 200605930 B ZA200605930 B ZA 200605930B ZA 200605930 A ZA200605930 A ZA 200605930A ZA 200605930 A ZA200605930 A ZA 200605930A ZA 200605930 B ZA200605930 B ZA 200605930B
- Authority
- ZA
- South Africa
- Prior art keywords
- ethyl
- dipyrido
- diazepin
- oxido
- oxyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55935404P | 2004-04-02 | 2004-04-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200605930B true ZA200605930B (en) | 2007-12-27 |
Family
ID=34963561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200605930A ZA200605930B (en) | 2004-04-02 | 2006-07-18 | Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxyl}ethyl}-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-one |
Country Status (19)
Country | Link |
---|---|
US (1) | US7309700B2 (xx) |
EP (1) | EP1740586A2 (xx) |
JP (1) | JP2007530681A (xx) |
KR (1) | KR20070014164A (xx) |
CN (1) | CN1938306A (xx) |
AR (1) | AR048360A1 (xx) |
AU (1) | AU2005230922A1 (xx) |
BR (1) | BRPI0509586A (xx) |
CA (1) | CA2558817A1 (xx) |
EA (1) | EA200601816A1 (xx) |
EC (1) | ECSP066904A (xx) |
IL (1) | IL178352A0 (xx) |
MX (1) | MXPA06011324A (xx) |
NO (1) | NO20064422L (xx) |
PE (1) | PE20060164A1 (xx) |
TW (1) | TW200602340A (xx) |
UY (1) | UY28827A1 (xx) |
WO (1) | WO2005097796A2 (xx) |
ZA (1) | ZA200605930B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1983997A4 (en) * | 2006-01-31 | 2009-06-17 | Thallion Pharmaceuticals Inc | CRYSTALLINE FORMS OF A FARNESYL DIBENZODIAZEPINONE |
US9150539B2 (en) | 2012-09-26 | 2015-10-06 | Merck Sharp & Dohme Corp. | Crystalline form of a reverse transcriptase inhibitor |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI270547B (en) * | 2000-06-16 | 2007-01-11 | Boehringer Ingelheim Ca Ltd | Non-nucleoside reverse transcriptase inhibitors |
US6759533B2 (en) * | 2002-06-28 | 2004-07-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors |
-
2005
- 2005-03-18 US US11/083,401 patent/US7309700B2/en active Active
- 2005-03-23 MX MXPA06011324A patent/MXPA06011324A/es unknown
- 2005-03-23 BR BRPI0509586-7A patent/BRPI0509586A/pt not_active Application Discontinuation
- 2005-03-23 KR KR1020067023046A patent/KR20070014164A/ko not_active Application Discontinuation
- 2005-03-23 EA EA200601816A patent/EA200601816A1/ru unknown
- 2005-03-23 CA CA002558817A patent/CA2558817A1/en not_active Abandoned
- 2005-03-23 JP JP2007506248A patent/JP2007530681A/ja active Pending
- 2005-03-23 AU AU2005230922A patent/AU2005230922A1/en not_active Abandoned
- 2005-03-23 WO PCT/US2005/009655 patent/WO2005097796A2/en active Application Filing
- 2005-03-23 CN CNA2005800104438A patent/CN1938306A/zh active Pending
- 2005-03-23 EP EP05729416A patent/EP1740586A2/en not_active Withdrawn
- 2005-03-30 UY UY28827A patent/UY28827A1/es not_active Application Discontinuation
- 2005-03-31 PE PE2005000373A patent/PE20060164A1/es not_active Application Discontinuation
- 2005-04-01 AR ARP050101292A patent/AR048360A1/es unknown
- 2005-04-01 TW TW094110415A patent/TW200602340A/zh unknown
-
2006
- 2006-07-18 ZA ZA200605930A patent/ZA200605930B/xx unknown
- 2006-09-28 IL IL178352A patent/IL178352A0/en unknown
- 2006-09-29 NO NO20064422A patent/NO20064422L/no not_active Application Discontinuation
- 2006-10-02 EC EC2006006904A patent/ECSP066904A/es unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0509586A (pt) | 2007-10-09 |
ECSP066904A (es) | 2006-12-20 |
PE20060164A1 (es) | 2006-04-03 |
EP1740586A2 (en) | 2007-01-10 |
US20050222134A1 (en) | 2005-10-06 |
KR20070014164A (ko) | 2007-01-31 |
CA2558817A1 (en) | 2005-10-20 |
NO20064422L (no) | 2006-09-29 |
EA200601816A1 (ru) | 2007-04-27 |
IL178352A0 (en) | 2007-02-11 |
WO2005097796A2 (en) | 2005-10-20 |
US7309700B2 (en) | 2007-12-18 |
MXPA06011324A (es) | 2007-03-21 |
UY28827A1 (es) | 2005-10-31 |
JP2007530681A (ja) | 2007-11-01 |
TW200602340A (en) | 2006-01-16 |
AR048360A1 (es) | 2006-04-19 |
AU2005230922A1 (en) | 2005-10-20 |
WO2005097796A3 (en) | 2006-01-05 |
CN1938306A (zh) | 2007-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180578T1 (hr) | Pirolo[2,3-b]piridin-4-il-amini i pirolo[2m3-b]pirimidin-4-il-amini kao inhibitori janus kinaze | |
IL183587A0 (en) | Methods of using [3.2.0] heterocyclic compounds and analogs thereof | |
ZA200708490B (en) | Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a, 12b-tetrahydro-1H-dibenz[2,3:6,7] oxepino[4,5-c]pyrrole | |
EP1653969A4 (en) | PYRROLO 1,2-B PYRIDAZINE DERIVATIVES | |
ZA200909186B (en) | 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives,preparation thereof and therapeutic use thereof | |
TWI365189B (en) | Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives | |
HK1122808A1 (en) | Preparation and use of tetrahydropyrrolo [3, 2-c]t pyridin-4-one derivatives for treatment of obesitty, psychiatric and neurological disorders | |
ZA201001214B (en) | 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapuetic application thereof | |
IL178220A0 (en) | Tetraazabenzo[e] azulene derivatives and analogs thereof | |
IL189276A0 (en) | Novel crystalline form of a pyridazino [4,5-b] indole derivative | |
IL189667A0 (en) | 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives | |
IL182800A0 (en) | Formulations of[1,4]diazepino[6,7,1-ij]quinoline derivatives | |
ZA200507192B (en) | Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives | |
AU2003251247A1 (en) | Methods for preparation of olanzapine polymorphic form i | |
IL211141A0 (en) | 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof, and therapeutic application thereof | |
PT2020410E (pt) | Derivados de pirido[2,3-d]pirimidina, sua preparação, sua aplicação em terapêutica | |
IL182755A0 (en) | Metabolites of certain [1,4]diazepino | |
IL181766A0 (en) | A process for the preparation of [1,4,5]-oxadiazepine derivatives | |
ZA200610587B (en) | 1-Heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones | |
ZA200605930B (en) | Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxyl}ethyl}-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-one | |
IL187441A0 (en) | Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid | |
HK1105976A1 (en) | Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof | |
ZA200802824B (en) | Methods of 1 H-imidazo[4,5-c]pyridines and analogs thereof | |
TW200730526A (en) | Process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-B:2',3'-E][1,4]diazepin-6-one | |
EP2044937A4 (en) | ANALGESIC DERIVATIVES 5,9 - METHANOCYCLO OCTA (B) PYRIDINE - 2 (1H) - ONE, PROCESS FOR PREPARING SAME AND USE THEREOF |